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ABSTRACT 
 
 
Drug Utilization Study of Insulin in Patients with Type 2 Diabetes 
(Studied in Outpatient Installation Airlangga Hospital Surabaya) 
 
Background: Diabetes Melitus (DM) is a group of metabolic disorders 
characterized by hyperglycemia resulting from defects in insulin action and 
associated with complications microvascular or macrovascular, therefore 
intensive therapy is important. Insulin is an antidiabetic drug that indicated 
for type 2 diabetes mellitus, who failed to achieve glycemic control with 
OAD therapy. The early initiation of insulin has been shown to improve 
glycemic control. 
Objective: The purposes of this study were examine utilization of insulin in 
patients with type 2 diabetes melitus and  identify drug related problems 
(DRP) in patients with insulin therapy. 
Method: Data was collected crossectionally with purposive sampling 
method in the period March 2016 until May 2016 in Outpatient Installation 
Airlangga Hospital Surabaya. The inclusion criteria were patient type 2 
diabetes mellitus using insulin therapy or in combination insulin-OAD 
therapy and the patients were willing to follow this study.  
Results: The results of observational study on 240 patients showed insulin 
therapy that used in this study were 30.83% patients used monotherapy 
insulin or basal bolus therapy and 69.17% patients used combination of 
insulin−OAD. These insulins were long acting insulin (72.50%) consist of 
glargine and detemir ; rapid acting insulin (41.67%) consist of aspart and 
glulisine; premixed insulin (25.83%) consist of 70/30 protamine 
aspart/aspart and 75/25 protamine lispro/lispro. Dose of insulin therapy in 
type 2 diabetes mellitus are very diverse and appropriated with individual 
pastient’s condition. In this study, only 20.82% patients achieve targeted 
blood glucose. There were any drug related problems identified, such as 
adverse drug reaction (14.59%),and drug interaction between insulin-aspirin 
(16.25%), insulin-golongan fibrat (7.92%), insulin-βbloker (5.83%),and 
insulin-ACEI (4.58%). 
Conclusion: The antidiabetic therapy which applied to the diabetes melitus 
patients were very complicated and individual. Some of patients’s blood 
glucose were still uncontrolled and several drug related problems were 
found in an antidiabetic therapy. 
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